Tianyu Biotech returned 2 million idled funds ahead of schedule, and the remaining amount will be fully repaid before the deadline.

On August 12, 2025, Tianyu Biotechnology Co., Ltd. held the forty-second meeting of the fourth session of the board of directors. The board reviewed and approved the proposal to continue using idle raised funds not exceeding 61.5 million yuan to temporarily supplement working capital, with a term of no more than twelve months. According to the progress of fundraising investment projects and the fund requirements, the company returned 2 million yuan to the dedicated fundraising account on September 23rd and informed the sponsor institution and sponsor representative. As of the announcement date on September 24th, the company has returned a total of 2 million yuan, and the remaining fundraising funds for temporary replenishment of working capital will be fully repaid before the due date. The company will fulfill its disclosure obligations in a timely manner.